A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01670045 · COMPLETED
Trial details
- NCT number
- NCT01670045
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-03-01
- Primary completion
- 2014-06-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.